1. Academic Validation
  2. Migrastatin acts as a muscarinic acetylcholine receptor antagonist

Migrastatin acts as a muscarinic acetylcholine receptor antagonist

  • J Antibiot (Tokyo). 2006 Nov;59(11):685-92. doi: 10.1038/ja.2006.91.
Koichi Nakae 1 Yoshio Nishimura Syunichi Ohba Yuzuru Akamatsu
Affiliations

Affiliation

  • 1 Bioactive Molecules Research Group, Microbial Chemistry Research Center, 3-14-23 Kamiosaki, Shinagawa-ku, Tokyo 141-0021, Japan. nakaek@bikaken.or.jp
Abstract

Migrastatin and its analogs have various biological activities such as inhibition of cell migration and anchorage-independent growth of Cancer cells. Although its biosynthesis and chemical synthesis have been under investigation, little is known about the biological target of migrastatin. Here, we found that migrastatin inhibited intracellular calcium mobilization induced by carbachol in neuroblastoma SK-N-SH cells without affecting Ca2+ mobilization and cAMP accumulation induced by ligands of other receptors. The binding of [3H] N-methylscopolamine, an antagonist for muscarinic receptor was also inhibited by migrastain. Functionally, migrastatin inhibited Ca2+ mobilization induced by carbachol in primary cultures of smooth muscle cells of rat bladder. This study reveals that migrastatin acts as a Muscarinic Acetylcholine Receptor antagonist.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-I0466
    戊二酰亚胺相关化合物